Tesamorelin — Growth Hormone Releasing Factor (GHRH)
Tesamorelin — Lyophilised Research Material
Tesamorelin is a synthetic Growth Hormone Releasing Hormone (GHRH) analogue supplied as a lyophilised laboratory research material manufactured in Switzerland and sealed in sterile laboratory vials to maintain structural stability during transport and storage.
Tesamorelin is widely utilised in endocrine and metabolic research due to its selective stimulation of pituitary growth hormone signalling pathways without direct exogenous hormone administration.
Research interest commonly focuses on its role in visceral adipose tissue regulation, particularly central abdominal fat distribution pathways and metabolic signalling associated with trunk fat deposition.
Available quantities: 10 mg
Physical form: Lyophilised solid
Reconstitution: Required prior to laboratory use
Suggested diluent: bacteriostatic water or suitable laboratory buffer
Storage: 2–8°C following reconstitution
Each production batch undergoes independent analytical verification with purity ≥99.5% confirmed by HPLC.
For laboratory research and analytical use only.
Not for human or veterinary application.